Handbook of Statistics in Clinical Oncology - Bookswagon UAE
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Handbook of Statistics in Clinical Oncology

Handbook of Statistics in Clinical Oncology


     0     
5
4
3
2
1



Out of Stock


Notify me when this book is in stock
X
About the Book

Since the third edition of this Handbook, significant advances have transformed the field of oncology. Most cancer types now offer multiple treatment options, with immunotherapies and targeted therapies becoming the standard of care. Master protocols, which allow the addition of new treatment arms without requiring new protocols, have gained popularity—not only to expedite the approval process for new therapies but also to ensure that patients receive the most beneficial treatments tailored to their individual needs. This revised edition features contributions from leading cancer trial statisticians, providing expert insights into modern oncology trial design and methodology. The Handbook is structured into five key sections: Part 1: Cancer prevention and screening trial designs, including risk prediction models and prevention trials. Part 2: Early-phase trial designs, covering dose-finding studies, selection designs, and multi-strata trials. Part 3: Late-stage trial designs, including approaches for IO therapies, cure-rate models, targeted agents, and considerations for pediatric oncology trials. Part 4: Trial conduct and operations, addressing best practices for Data Monitoring Committees (DMCs), SWOG/CRAB calculators, pragmatic trials, and clinical trial innovation. Part 5: Beyond primary endpoints, exploring surrogate endpoints, microbiome research, patient-reported outcomes (PROs), and tree-based partitioning methods. This updated edition provides a comprehensive resource for researchers, clinicians, and statisticians involved in the evolving landscape of oncology clinical trials. Key Features: Practical guidance on designing and conducting oncology clinical trials Advanced statistical methodologies tailored oncology clinical trials Best practices for trial execution and management Key considerations for primary, secondary, and ancillary endpoint considerations

Table of Contents:
SECTION 1 Cancer Prevention & Screening Chapter 1 Cancer Screening Trials Chapter 2 Cancer Risk Prediction Models Chapter 3 Incorporating External Registry Data Into Cohort-based Cancer Risk Prediction Tools SECTION 2 Trial Design | Early-Phase Trials Chapter 4 Phase I – Overview and Recent Trial Designs Chapter 5 Statistical and Machine Learning Methods for Phase I Dose-Finding Chapter 6 Seamless Phase I/II Trial Design for Assessing Toxicity and Efficacy for Targeted Agents Chapter 7 Designs Using Time to Event Endpoints / Single Arm versus Randomized Phase II Designs Chapter 8 Phase II Selection Designs Chapter 9 Phase II Trials with Multiple Strata SECTION 3 Trial Design | Late-Phase Trials Chapter 10 Cure Rate Survival Models Chapter 11 Phase III Trials for Targeted Agents Chapter 12 Phase II and III Clinical Trial Designs for Precision Medicine Chapter 13 SMARTs in Oncology Chapter 14 Statistical Considerations in the Design and Analysis of Cancer Trials with Immune-Oncology Therapies Chapter 15 Alpha Splitting Chapter 16 Early Stopping of Clinical Trials Evaluating Targeted Therapies Chapter 17 Noninferiority Trials Chapter 18 Considerations for Pediatric Oncology Trials SECTION 4 Trial Conduct Chapter 19 An Overview of Master Protocols Chapter 20 On Use of Covariates in Randomization and Analysis of Clinical Trials Chapter 21 Pragmatic Clinical Trials in Clinical Oncology: A Statistical Perspective Chapter 22 Dynamic Treatment Regimens and Sequential Multiple Assignment Randomized Trial in Cancer Research Chapter 23 Outcome-Adaptive Randomization Chapter 24 Current Suggested Practices and Issues for Data and Safety Monitoring Committees in Cancer Clinical Trials Chapter 25 Improving Data Collection: EHR-to-EDC Assisted Data Transfer Chapter 26 Barriers and Disparities in Access to Cancer Clinical Trials – Causes and Implications Chapter 27 SWOG Statistical Calculators for Design and Analysis of Clinical Trials Chapter 28 Streamlining Data Collection and Trial Conduct SECTION 5 Beyond the Primary Endpoint Chapter 29 Use of Circulating Tumor DNA in Oncology – ctMoniTR Chapter 30 Statistical Analysis of -Omics Data Chapter 31 Principles of Design and Analysis for Patient-Reported Outcomes Chapter 32 X Intermediate and Surrogate Endpoints in Phase III Randomized Chapter 33 Prognostic Groups via Interpretable Function Approximation: Tree-based and Extreme Regression Models

About the Author :
Antje Hoering is the President and CEO of Cancer Research And Biostatistics (CRAB) and leads a team of approximately eighty talented and dedicated oncology research professionals, all united in our mission to help conquer cancer. She also serves as the lead statistician of the SWOG Myeloma Committee and holds affiliate appointments at the University of Washington Biostatistics department and the Fred Hutch Cancer Center. Megan Othus is a Professor of Biostatistics at the Fred Hutchinson Cancer. She serves as the lead statistician of the SWOG Leukemia and Rare Cancer Committees. Her research interests focus on the design and endpoints in oncology clinical trials. John Crowley received his master’s and doctorate degrees (in 1970 and 1973, respectively) in Biomathematics from the University of Washington, and was the Director of the SWOG Statistical Center from 1984 to 2012. In 1997 Dr. Crowley founded Cancer Research And Biostatistics (CRAB), was the President and CEO of CRAB until 2014, and currently serves as the Chief of Strategic Alliances. Dr. Crowley's research interests focus on the design and analysis of cancer clinical and translation trials.


Best Sellers


Product Details
  • ISBN-13: 9781032596952
  • Publisher: Taylor & Francis Ltd
  • Publisher Imprint: Chapman & Hall/CRC
  • Height: 254 mm
  • No of Pages: 584
  • ISBN-10: 1032596953
  • Publisher Date: 30 Dec 2025
  • Binding: Hardback
  • Language: English
  • Width: 178 mm


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Handbook of Statistics in Clinical Oncology
Taylor & Francis Ltd -
Handbook of Statistics in Clinical Oncology
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Handbook of Statistics in Clinical Oncology

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    Fresh on the Shelf


    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!